Surrey Heartlands

Joint Formulary & PAD

Fondaparinux sodium - VTE prevention post hip/knee replacement

You are here : Home > Formulary Search > Fondaparinux sodium - VTE prevention post hip/knee replacement

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
Caution - potential for latex reactions in allergic patients.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Fondaparinux sodium
Indication :
VTE prevention post hip/knee replacement
Group Name :
Keywords :
Brand Names Include :
Arixtra
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Fondaparinux sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat VTE prevention post hip/knee replacement.

Committee Recommendations (0)

  • No records returned.